Get In Touch

Pharmacologic stress agents are employed in pharmacologic stress testing such as cardiovascular stress test, which is used along with well-known imaging modalities such as echocardiography (ECG) and radionuclide imaging tests. Cardiovascular stress test is an advanced version of exercise testing using treadmill bicycle exercise in coordination with blood pressure monitoring and ECG. The pharmacologic stress agent and nuclear tracer are injected through intravenous (IV) line while the heart rate, blood pressure, and ECG are monitored continuously before the test as well as during and after the test is completed. The most commonly used pharmacologic stress agents are adenosine, dobutamine, dipyridamole, and regadenoson, which functions as cardiac vasodilators. These pharmacologic stress agents are involved in dilation of coronary vessels, increasing the velocity and flow rate of the blood in blood vessels while exhibiting less response in case of stenotic vessels. This difference in response results into steal of flow and this perfusion defect is detected in nuclear scans. 

Adenosine is commonly found in human tissues which functions to regulate blood flow in myocardium and other vascular beds. Dipyridamole works by increasing intravascular adenosine levels, causing indirect coronary vasodilation due to adenosine deamination and intracellular reuptake inhibition, respectively. Response of the heart to dobutamine is similar to the way the heart reacts to physical exercise as it functions as cardiac chronotrope and inotrope. 

The global pharmacologic stress agents market is driven by an alarming rise in number of coronary heart diseases worldwide. According to a recent report published in The Lancet, there has been 24% rise in the number of people with peripheral arterial disease (PAD) in the last decade. Globally, millions of people are suffering from heart rhythm disorder atrial fibrillation, commonly called as AFib. Currently, nearly 2.7 million people in the U.S. are living with AFib due to rise in geriatric population, and this number is expected to rise dramatically in the next few years. The formation of atheromatous plaque is one of the main reasons which can cause heart attack or stroke. Other causes for the rise in heart diseases include smoking, obesity, and changes in lifestyle. However, growth of the global pharmacologic stress agents market can be restrained by side effects and safety issues related to the use of pharmacologic stress agents. People may experience side effects depending on the individual conditions. The most common side effects of the agents include headache, flushing, chest pain, nausea, feeling hot, and dizziness. Other factors which are likely to hinder the market growth are rise in the cost of the pharmacologic stress agents and the cardiovascular stress test. In addition, availability of effective and low-cost alternative test to pharmacologic stress testing, such as arm exercise, is expected to slow the market growth.   

The global pharmacologic stress agents market has been segmented into agent type, application, end-user, and geography. By agent type, the market is segmented into adenosine, dobutamine, dipyridamole, regadenoson, and others. In terms of application, the market is segmented into ECG stress, echocardiography, nuclear imaging test, magnetic resonance imaging (MRI), and computed tomography (CT) scan. The nuclear imaging test segment is sub-segmented into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Based on end-user, the market is classified into hospitals and specialized diagnostic centers. Based on region, the market is distributed over North America (NA), Europe, Latin America (LA), Asia Pacific (APAC), and Middle East & Africa (MEA). 

Key players operating in the pharmacologic stress agents market are Astellas Pharma, Inc., Cardinal Health, Rapiscan Pharma Solutions, and GE Healthcare.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Pharmacologic Stress Agents Market